Document is current
Any future updates will be listed below
-
Authors
Tian, Zhuang
Peng, Daoquan
Ma, Wei
Yan, Jiangtao
Wang, Jian’an
Tang, Yida
Jin, Wei
Liu, Ying
Jia, Caiping
Gao, Yingxu
Gong, Yankun
Sun, Xiaohong
Chen, Naihan
Zhu, Shuiqing
Zhang, Shuyang
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 27 January 2025
First Online: 23 May 2025
Declarations
:
: Zhuang Tian, Daoquan Peng, Wei Ma, Jiangtao Yan, Jian'an Wang, Wei Jin, Yida Tang, Ying Liu, and Shuyang Zhang have nothing to disclose. Caiping Jia, Yingxu Gao, Yankun Gong, Xiaohong Sun, Naihan Chen, and Shuiqing Zhu: employees of Pfizer and hold share/share options.
: The study was conducted according to ethical principles derived from the Declaration of Helsinki, Council for International Organizations of Medical Sciences International Ethical Guidelines, and the International Council for Harmonisation Good Clinical Practice guidelines. The study followed all local laws and regulations. Study materials were reviewed and approved by Ethics Committees or Institutional Review Boards at each participating center (Table S1; Approval number at the primary site [Peking Union Medical College Hospital]: KS2021004). All patients (or their legal representatives) provided written informed consent.
